olmesartan has been researched along with me 3221 in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (me 3221) | Trials (me 3221) | Recent Studies (post-2010) (me 3221) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 7 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giridhar, R; Murumkar, P; Naik, P; Yadav, MR | 1 |
1 review(s) available for olmesartan and me 3221
| Article | Year |
|---|---|
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan | 2010 |